Loading…
← CockpitCompetitor Analysis › 241710.KS Cosmecca Korea Co. LtdOpen in the cockpit ↗

Cosmecca Korea Co. Ltd241710.KSCompetitor analysis, valuation and peers

South Korea · KRW·Consumer Staples›Household/Personal Care
Momentum leader 88
Mkt cap
$847M
US dollars, full cap
Free float
61%
of shares outstanding
$/day
$7.48M
20-day average traded
Fwd P/E
16.3×
forward earnings
ROIC−WACC
+8.1 pp
WACC 5.3%
Hurdle
n/a
no reverse DCF
Next earnings
93 days
19 Feb 2027
Close · KRW₩106,900
1D+8.6%
1W+11.9%
1M-0.6%
3M-16.0%
6M+23.3%
YTD+60.5%
1Y+57.7%
ATR %7.9%
52w lowhigh31.2% off high

What Cosmecca Korea does

Employees: 506

Cosmecca Korea at a glance

Size Cosmecca Korea (241710.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $847M, the 266th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩106,900 on 18 Nov 2026.

Performance Over six months the shares gained 23.3%, against +4.3% for the median peer and -37.2% for the South Korea market (cap-weighted) — 5th highest of 21 in its peer set.

Growth Revenue grew 41.7% over the last twelve months (peer median +10.2%); the operating margin is 11.9% (peer median 8.9%).

Valuation It trades at 16.3× forward earnings against a peer median of 18.9× (7th cheapest of 20).

Capital Return on invested capital runs 8.1 points above its cost of capital (5.3% WACC).

Next results Next results expected around 19 Feb 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026241710.KS 125Peer median 107
Six months, rebased to 100: Cosmecca Korea against the median of its 20 peers (local-currency closes).

Cosmecca Korea financials

Reported figures in KRW; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₩837B₩641B₩524B₩471B₩399B
Revenue growth—+22%+11%+18%—
Gross profit₩183B₩155B₩119B₩102B₩59.8B
EBITDA₩119B₩100B₩78.2B₩65.8B₩27.1B
Net income₩58.0B₩45.4B₩42.8B₩22.3B₩2.66B
Free cash flow-₩6.22B-₩6.34B₩20.8B₩23.4B₩5.12B
Capital expenditure₩53.9B₩61.5B₩49.0B₩18.7B₩11.8B
Total debt₩260B₩172B₩122B₩109B₩121B

Quarterly statements and history in the cockpit →

Cosmecca Korea competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%GALAXYSURF300740001328603193301108JYOTHYLAB4919492860500926574836502145BAJAJCONEPC003006PZCICOS301371002790241710.KS6-month return →1-month return →
Up and to the right = strong over both horizons. Cosmecca Korea is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%+80%20×40×GALAXYSURF300740001328603193301108JYOTHYLAB4919492860500926574836502145BAJAJCONEPC003006PZC002790241710.KSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Cosmecca Korea is the large dot.

Cosmecca Korea competitors and peer comparison

How Cosmecca Korea compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Cosmecca Korea against its 20 peers (data as of 18 Nov 2026)
Measure241710.KSPeer medianRank in peer set
1-month return-0.6%-3.5%9th highest of 21
6-month return+23.3%+4.3%5th highest of 21
Distance from 52-week high-31.2%-33.1%11th highest of 21
Revenue growth (TTM)+41.7%+10.2%3rd highest of 21
Operating margin11.9%8.9%8th highest of 21
Forward P/E16.3×18.9×7th cheapest of 20
ROIC minus cost of capital+8.1 pp+6.2 pp10th highest of 21
EV / EBITDA11.4×9.6×3rd most expensive of 13
Net debt / EBITDA1.4×-1.1×2nd most indebted of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Cosmecca Korea 241710.KSSouth Korea$847M+23%+42%12%16.3×n/an/a
Galaxy Surfactants GALAXYSURF.NSIndia$845M+22%+30%9%17.6×18.5%+13.7%
SYoung 300740.SZChina$816M-48%+14%3%33.4×14.0%+6.1%
Dencare (Chongqing) Oral Care 001328.SZChina$912M+13%+10%11%27.9×3.7%+10.8%
Runben Biotechnology 603193.SSChina$918M-30%+13%21%18.5×1.5%+28.4%
Tongling Jieya Biologic Technology 301108.SZChina$933M+56%+24%5%52.5×28.5%+0.8%
Jyothy Labs JYOTHYLAB.NSIndia$762M-9%+5%8%40.8×34.5%+8.9%
Milbon 4919.TJapan$743M+48%+8%14%25.7×-3.3%+8.2%
Noevir 4928.TJapan$978M+7%-3%28%20.4×-12.8%+4.1%
Hangzhou Haoyue Personal Care 605009.SSChina$726M-18%+10%6%17.7×4.4%+7.7%
Shanghai Forest Cabin Cosmetics 2657.HKHong Kong$1.04B+15%+74%18%11.8×11.3%+49.0%
d'Alba Global 483650.KSSouth Korea$1.13B-55%+49%22%12.0×-6.6%+53.0%
Shanghai Chicmax Cosmetics 2145.HKHong Kong$1.17B-42%+23%8%14.4×-6.1%+21.2%
Bajaj Consumer Care BAJAJCON.NSIndia$560M-24%+29%22%19.7×14.8%+5.0%
Edgewell Personal Care EPCUnited States$1.30B+67%-10%7%14.2×n/an/a
Chongqing Baiya Sanitary Products 003006.SZChina$1.35B+27%0%3%37.3×28.8%+22.8%
PZ Cussons PZC.LUnited Kingdom$527M+13%+5%11%12.7×-2.3%-2.1%
Intercos ICOS.MIItaly$1.43B+12%-5%9%18.9×4.3%+11.5%
Harbin Fuerjia Technology 301371.SZChina$1.51B-39%+28%20%21.4×7.5%+3.6%
Qingdao Kingking Applied Chemistry 002094.SZChina$454M-26%+3%4%n/an/an/a
AMOREPACIFIC 002790.KSSouth Korea$1.61B+2%+9%9%8.5×-5.7%-1.3%

Questions

Which companies are Cosmecca Korea's closest peers?
The cockpit's peer set: Galaxy Surfactants (GALAXYSURF.NS), SYoung (300740.SZ), Dencare (Chongqing) Oral Care (001328.SZ), Runben Biotechnology (603193.SS), Tongling Jieya Biologic Technology (301108.SZ), Jyothy Labs (JYOTHYLAB.NS), Milbon (4919.T), Noevir (4928.T).
Is Cosmecca Korea expensive compared with its peers?
On forward p/e it trades at 16.3× against a peer median of 18.9×, 7th cheapest of 20 in its peer set.
How has Cosmecca Korea stock performed?
Over six months to 18 Nov 2026 the shares returned +23.3% against +4.3% for the median peer; over one year +57.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.